EyePoint Pharmaceuticals widens losses

EyePoint Pharmaceuticals Inc. (Nasdaq: EYPT) widened third quarter losses sending the stock price down 55 cents to close at $2.00.


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.